Medicare Enrolled
Dr. Richard Lacalamito, DO
Family Medicine · Winter Haven, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lacalamito from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lacalamito? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lacalamito
Dr. Richard Lacalamito is a family medicine in Winter Haven, FL, with 20 years in practice. Based on federal Medicare data, Dr. Lacalamito performed 19,948 Medicare services across 8,809 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lacalamito received a total of $14,514 from 46 pharmaceutical and/or device companies across 1026 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lacalamito is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 1% volume in FL$ $14,514 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,948
Medicare services
Top 1% in FL for family medicine
8,809
Unique beneficiaries
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~997 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,300 | $18 | $41 |
| Contrast dye for imaging (iodine-based) | 1,560 | $0 | $2 |
| MRI contrast dye injection (gadobutrol) | 1,255 | $0 | $1 |
| Office visit, established patient (30-39 min) | 1,161 | $84 | $244 |
| Blood draw (venipuncture) | 1,118 | $8 | $10 |
| Comprehensive metabolic blood panel | 940 | $10 | $30 |
| Lipid panel (cholesterol and triglycerides) | 853 | $13 | $38 |
| Complete blood count (CBC) with differential | 835 | $8 | $25 |
| Urinalysis with microscopic exam | 734 | $3 | $15 |
| Thyroid stimulating hormone (TSH) test | 618 | $16 | $53 |
| Urine microalbumin test (kidney screening) | 566 | $6 | $8 |
| Creatinine test (kidney function) | 566 | $5 | $17 |
| Creatine kinase (cardiac enzyme) level, total | 499 | $6 | $21 |
| Free thyroxine (T4) test | 479 | $9 | $30 |
| Vitamin D level test | 470 | $29 | $85 |
| Drug injection, under skin or into muscle | 452 | $10 | $33 |
| Office visit, established patient (20-29 min) | 445 | $60 | $172 |
| Hemoglobin A1c test (diabetes monitoring) | 427 | $9 | $25 |
| Vitamin B-12 level test | 403 | $15 | $60 |
| Injection, ketorolac tromethamine, per 15 mg | 374 | $0 | $10 |
| Flu vaccine administration | 248 | $29 | $30 |
| Flu vaccine, high-dose | 202 | $71 | $117 |
| Urine culture, bacterial colony count | 186 | $8 | $24 |
| Injection, methylprednisolone acetate, 80 mg | 138 | $8 | $16 |
| Ceftriaxone antibiotic injection | 120 | $0 | $1 |
| 3D screening mammography (tomosynthesis) | 114 | $52 | $75 |
| Screening mammography | 113 | $125 | $255 |
| Prostate cancer screening; prostate specific antigen test (psa) | 107 | $19 | $55 |
| Bacterial culture, aerobic | 96 | $8 | $25 |
| Antibiotic sensitivity test | 96 | $8 | $25 |
| Annual wellness visit, follow-up | 92 | $123 | $248 |
| Ferritin level test (iron stores) | 89 | $13 | $40 |
| Iron level test | 86 | $6 | $18 |
| Iron binding capacity test | 86 | $8 | $24 |
| Chest X-ray, 2 views | 70 | $23 | $65 |
| Bone density scan (DEXA) | 68 | $37 | $99 |
| Folic acid level test | 63 | $14 | $60 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 63 | $1 | $8 |
| PSA test (prostate cancer screening) | 55 | $18 | $55 |
| Electrocardiogram (EKG), 12-lead | 55 | $11 | $55 |
| Transitional care management services for problem of at least moderate complexity | 53 | $158 | $389 |
| Prothrombin time test (blood clotting) | 52 | $4 | $14 |
| Administration of vaccine | 41 | $15 | $31 |
| Uric acid level test | 39 | $4 | $18 |
| Flu vaccine, quadrivalent | 35 | $76 | $118 |
| New patient office visit (45-59 min) | 34 | $89 | $329 |
| Red blood count, automated test | 32 | $4 | $12 |
| COVID-19 vaccine administration | 31 | $40 | $54 |
| COVID-19 vaccine (Moderna bivalent) | 31 | $143 | $220 |
| X-ray of knee, 4 or more views | 27 | $27 | $60 |
| Ldl cholesterol level | 27 | $10 | $27 |
| X-ray of lower and sacral spine, 2-3 views | 26 | $28 | $62 |
| Bacterial culture, any other source except urine, blood or stool, aerobic | 26 | $8 | $25 |
| Testosterone (hormone) level, total | 25 | $24 | $70 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 20 | $281 | $375 |
| Pneumonia vaccine administration | 20 | $29 | $30 |
| Hip X-ray, 2-3 views | 19 | $33 | $80 |
| Mri scan of lower spinal canal without contrast | 17 | $128 | $1,075 |
| Transitional care management services for problem of high complexity | 16 | $209 | $542 |
| CT scan of chest, without contrast | 15 | $81 | $485 |
| Removal of impacted ear wax | 14 | $33 | $90 |
| Screening test for autoimmune disorder | 14 | $12 | $35 |
| C-reactive protein test (inflammation marker) | 14 | $5 | $15 |
| Adm sarscv2 bvl 50mcg/.5ml a | 13 | $40 | $45 |
| Sed rate test (inflammation marker) | 13 | $3 | $15 |
| Sarscov2 vac bvl 50mcg/0.5ml | 13 | $0 | $0 |
| Ct scan of abdomen and pelvis without contrast | 12 | $145 | $420 |
| Basic metabolic blood panel | 12 | $8 | $25 |
| X-ray of paranasal sinus, minimum of 3 views | 11 | $27 | $76 |
| Mri scan of brain without contrast | 11 | $159 | $985 |
| Mri scan of brain before and after contrast | 11 | $229 | $2,085 |
| Stool analysis for blood, by fecal hemoglobin determination by immunoassay | 11 | $16 | $44 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $165 | $317 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,514
Total received (2018-2024)
Avg $2,073/year across 7 years
Top 2% in FL for family medicine
46
Companies
1,026
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,344 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$170 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,275
2023$2,430
2022$2,539
2021$2,024
2020$470
2019$2,228
2018$2,547
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,084
Novo Nordisk Inc
$1,395
Janssen Pharmaceuticals, Inc
$1,372
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,056
PFIZER INC.
$965
GlaxoSmithKline, LLC.
$840
ABBVIE INC.
$801
Amgen Inc.
$710
Lilly USA, LLC
$539
Bayer HealthCare Pharmaceuticals Inc.
$358
Merck Sharp & Dohme LLC
$335
Biohaven Pharmaceutical Holding Company Ltd.
$274
SANOFI-AVENTIS U.S. LLC
$274
E.R. Squibb & Sons, L.L.C.
$270
Merck Sharp & Dohme Corporation
$261
Kowa Pharmaceuticals America, Inc.
$238
Supernus Pharmaceuticals, Inc.
$232
Allergan Inc.
$222
Astellas Pharma US Inc
$177
GENZYME CORPORATION
$170
IDORSIA PHARMACEUTICALS US INC
$169
Novartis Pharmaceuticals Corporation
$160
Daiichi Sankyo Inc.
$160
Bayer Healthcare Pharmaceuticals Inc.
$159
Biohaven Pharmaceuticals, Inc.
$147
Takeda Pharmaceuticals U.S.A., Inc.
$136
Dexcom, Inc.
$134
Exact Sciences Corporation
$127
Amarin Pharma Inc.
$116
AbbVie, Inc.
$109
Inari Medical, Inc.
$94
AbbVie Inc.
$64
Esperion Therapeutics, Inc.
$58
Horizon Therapeutics plc
$46
Sunovion Pharmaceuticals Inc.
$36
Eisai Inc.
$36
GRT US Holding, Inc.
$31
Corcept Therapeutics
$21
DEXCOM, INC.
$20
Abbott Laboratories
$20
Nevro Corp.
$20
Strongbridge US INC.
$20
Xeris Pharmaceuticals, Inc.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Mylan Specialty L.P.
$14
Orexigen Therapeutics, Inc.
$13
Top 3 companies account for 33.4% of total payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · AREXVY · Aimovig · Androgel · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · BYSTOLIC · CHANTIX · CONTRAVE · CREON · Cologuard Collection Kit · DALIRESP · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLOWTRIEVER CATHETER · FORTEO · GARDASIL · GARDASIL 9 · GEMTESA · INJECTAFER · INVOKANA · JANUVIA · JARDIANCE · KEVEYIS · Kerendia · Korlym · LEQVIO · LINZESS · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Myrbetriq · NEXLETOL · NURTEC ODT · Omnia · Otezla · Ozempic · PENNSAID · PNEUMOVAX 23 · PRADAXA · PREMARIN · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · Prolia · QULIPTA · QUVIVIQ · Qutenza · RYBELSUS · Repatha · Rybelsus · S · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SPRAVATO · STEGLATRO · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · Synthroid · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · Tresiba · Trintellix · UBRELVY · Uloric · VERQUVO · VESICARE · VIBERZI · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED · YUPELRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in FL.
Equivalent to $73 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
260
Per 100K population
34.2
County median income
$63,644
Nearest hospital
WINTER HAVEN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lacalamito is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (low-engagement, top 2%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lacalamito experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Lacalamito performed 3,300 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lacalamito receive payments from pharmaceutical companies?
Yes. Dr. Lacalamito received a total of $14,514 from 46 companies across 1,026 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lacalamito's costs compare to other family medicines in Winter Haven?
Dr. Lacalamito's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lacalamito) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Winter Haven
Browse family medicines in Winter Haven ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in FL
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in FL
Which FL family medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology